As part of a new build facility for Medimmune for the production of FluMist, an Influenza vaccine, Valcomm was appointed by the principal contractors to provide qualification support, thermal mapping and calibration for the facility.
The qualification effort spanned extremes of temperature from -196°C cryogenic storage chambers to environmental chambers and egg incubators.